AP
Archit Pandharipande
AIIMS Nagpur, RGCI & RC, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Topiwala National Medical College & BYL Nair Charitable Hospital, POST GRADUATE INSTITIUTE OF CHILD HEALTH NOIDA
About
Good day to everyone.
I am Dr.Archit Pandharipande.
I care for people afflicted with hematological disorders together with a team under Dr.Nita Radhakrishnan mam.
I am interested in research for patients with hematological malignancies & Hemostasis & thrombosis both in children and adults.
Employment
-
AIIMS Nagpur Assistant professor2025 - Present
-
AIIMS Nagpur Senior Resident2025 - 2025
-
RGCI & RC Attending Consultant2025 - 2025
-
POST GRADUATE INSTITIUTE OF CHILD HEALTH NOIDA Assistant Professor2022 - 2024
Education
-
Sanjay Gandhi Post Graduate Institute of Medical Sciences DM2019 - 2022
-
Topiwala National Medical College & BYL Nair Charitable Hospital MD2015 - 2018
-
Government Medical College MBBS2009 - 2015
Projects & Funding
Projects & funding information is unavailable.
Publications (25)
- Haemophilia Care in India: A Multicentre Cross‐Sectional Analysis From the World Bleeding Disorders Registry Benchmarking Across Global Gross National Income Strata Save
- Managing massive gastrointestinal and abdominal haemorrhage in inherited bleeding disorders: experience from a pediatric cohort Save
- Patterns and Outcomes of Recurrence in Pediatric Langerhans Cell Histiocytosis Save
- Clinical outcomes and health-system challenges in congenital afibrinogenemia: a single-centre prospective case series Save
- PTCy-Based versus ATG-Based GVHD Prophylaxis in Mismatched Unrelated Donor HCT: A Secondary Analysis of CIBMTR Data Save
- Adolescent-Onset Familial Hemophagocytic Lymphohistiocytosis Triggered by Epstein Barr Virus: A Case Report of a Rare UNC13D Variant Save
- Managing heavy menstrual bleeding in adolescents with bleeding disorders: Outcomes from a pragmatic LMIC approach Save
- Congenital Thrombotic Thrombocytopenic Purpura Presenting as Isolated Thrombocytopenia Save
- Tertiary prophylaxis with extended half-life factor prophylaxis: a model to reduce disability in low- and middle-income countries Save
- Real-World Experience of Glofitamab in Refractory Lymphomas: A Compassionate-Use Program Experience Save